From: Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization
A. Clinicopathological features | Claudin-Low | All samples | |||||
---|---|---|---|---|---|---|---|
n | HR [95CI] | p-value | n | HR [95CI] | p-value | ||
Age at diagnosis, years | >50 vs ≤50 | 237 | 0.9 [0.57-1.4] | 0.636 | 2366 | 1.01 [0.87-1.16] | 0.923 |
Histological type | ILC vs IDC | 59 | 0.00 [0.00- Inf] | 0.837 | 624 | 1.09 [0.71-1.67] | 0.269 |
 | MED vs IDC |  | 0.45 [0.06-3.35] |  |  | 0.53 [0.20-1.42] |  |
 | MIX vs IDC |  | 0.00 [0.00- Inf] |  |  | 0.44 [0.18-1.06] |  |
 | other vs IDC |  | 1.90 [0.44-8.10] |  |  | 1.04 [0.57-1.92] |  |
Histological grade | 2-3 vs 1 | 270 | 3.63 [1.32-9.92] | 1.22E-02 | 2552 | 2.36 [1.86-3.01] | 2.84E-12 |
Pathological tumor size | pT2-3 vs pT1 | 155 | 2.33 [1.27-4.26] | 6.01E-03 | 1744 | 1.52 [1.29-1.8] | 6.83E-07 |
Pathological axillary lymph node status | positive vs negative | 194 | 2.23 [1.34-3.72] | 2.01E-03 | 2365 | 1.45 [1.26-1.68] | 3.95E-07 |
ESR1 expression status | positive vs negative | 343 | 0.38 [0.25-0.58] | 5.02E-06 | 3355 | 0.56 [0.5-0.63] | <2.0E-16 |
PGR expression status | positive vs negative | 343 | 0.56 [0.38-0.83] | 3.86E-03 | 3353 | 0.7 [0.63-0.79] | 2.24E-09 |
ERBB2 expression status | positive vs negative | 343 | 1.98 [0.92-4.26] | 0.079 | 3355 | 1.4 [1.18-1.65] | 7.22E-05 |
Triple-negative expression status | yes vs no | 343 | 2.19 [1.51-3.18] | 3.82E-05 | 3354 | 1.7 [1.49-1.94] | 1.22E-15 |
B. Gene expression signatures | Â | Â | Â | Â | Â | Â | |
70-gene GES [11] | Poor vs Good | 343 | 1.22 [0.74-2.02] | 0.435 | 3355 | 1.83 [1.57-2.12] | 3.00E-15 |
GGI [14] | Poor vs Good | 283 | 1.42 [0.92-2.2] | 0.113 | 2655 | 2.1 [1.82-2.43] | <2.0E-16 |
RS [46] | Intermediary vs Good | 343 | 2.73 [1.40-5.31] | 1.09E-03 | 3355 | 1.63 [1.38-1.93] | <2.0E-16 |
 | Poor vs Good |  | 3.03 [1.68-5.46] |  |  | 2.15 [1.87-2.47] |  |
ROR [41] | Intermediary vs Good | 343 | 1.28 [0.69-2.36] | 8.74E-03 | 3355 | 1.75 [1.45-2.10] | <2.0E-16 |
 | Poor vs Good |  | 1.85 [1.24-2.75] |  |  | 2.11 [1.85-2.41] |  |
Immune response metagene [50] | Poor vs Good | 343 | 1.17 [0.82-1.68] | 0.387 | 3354 | 1.19 [1.06-1.34] | 2.93E-03 |
LCK metagene [49] | Poor vs Good | 343 | 1.12 [0.78-1.6] | 0.541 | 3355 | 1.1 [0.96-1.26] | 0.152 |
Kinase immune metagene [48] | Poor vs Good | 343 | 1.14 [0.78-1.65] | 0.507 | 3355 | 1.04 [0.88-1.24] | 0.615 |
B-cell cluster [47] | Intermediary vs Good | 343 | 1.15 [0.74-1.79] | 0.0692 | 3353 | 1.20 [1.04-1.38] | 3.94E-05 |
 | Poor vs Good |  | 1.64 [1.07-2.52] |  |  | 1.38 [1.20-1.59] |  |